
Results
24
Companies which are more than 50% undervalued based on analyst price target.
24 companies
Samsung Epis Holdings
Market Cap: ₩9.4t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩379,000.00
7D
-6.0%
1Y
n/a
ABL Bio
Market Cap: ₩4.6t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩82,500.00
7D
-5.0%
1Y
1.7%
LigaChem Biosciences
Market Cap: ₩4.0t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩108,300.00
7D
-5.3%
1Y
-22.3%
Voronoi
Market Cap: ₩3.1t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩172,500.00
7D
-4.5%
1Y
59.0%
ST PharmLtd
Market Cap: ₩2.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩110,900.00
7D
3.1%
1Y
25.7%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,850.00
7D
1.4%
1Y
22.0%
L&C BIOLTD
Market Cap: ₩1.4t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩53,300.00
7D
-2.6%
1Y
75.6%
GC Biopharma
Market Cap: ₩1.4t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩125,400.00
7D
-3.2%
1Y
-3.8%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩120,900.00
7D
-1.9%
1Y
-9.8%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩42,500.00
7D
3.3%
1Y
-5.2%
Chong Kun Dang Pharmaceutical
Market Cap: ₩885.4b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩67,200.00
7D
-1.5%
1Y
-16.8%
DongKook Pharmaceutical
Market Cap: ₩834.5b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩18,500.00
7D
-9.5%
1Y
8.4%
Boryung
Market Cap: ₩773.0b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,150.00
7D
-0.3%
1Y
11.3%
Pharmicell
Market Cap: ₩711.6b
A biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally.
A005690
₩11,860.00
7D
-0.5%
1Y
10.0%
Dong-A Socio Holdings
Market Cap: ₩604.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩91,200.00
7D
-3.4%
1Y
-10.1%
AprilBioLtd
Market Cap: ₩584.6b
Develops long-acting type biobetter and antibody biologics.
A397030
₩21,250.00
7D
-27.1%
1Y
1.0%
Dong-A ST
Market Cap: ₩364.3b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩37,800.00
7D
-1.0%
1Y
-11.4%
Humedix
Market Cap: ₩273.0b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩26,450.00
7D
-2.4%
1Y
-51.3%
BINEX
Market Cap: ₩225.8b
Operates as a pharmaceutical company in South Korea.
A053030
₩7,090.00
7D
-2.9%
1Y
-52.6%
Whan In PharmLtd
Market Cap: ₩184.8b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩10,000.00
7D
-1.7%
1Y
-10.5%
Daewon Pharmaceutical
Market Cap: ₩167.4b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩7,810.00
7D
-2.1%
1Y
-39.9%
Daihan PharmaceuticalLtd
Market Cap: ₩156.4b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩26,600.00
7D
-1.3%
1Y
-9.4%
Macrogen
Market Cap: ₩140.1b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,920.00
7D
2.7%
1Y
-17.2%
Samil PharmaceuticalLtd
Market Cap: ₩136.3b
Engages in the manufacture and sale of pharmaceuticals in South Korea.
A000520
₩6,380.00
7D
-6.0%
1Y
-34.2%